Therefore, we conducted a large HLA class I allele association study for NPM1mut and DNMT3A R882H-mutated AML at two-field resolution to confirm the concept that immune reactions against mutated NPM1 and/or DNMT3A can prevent AML development. The gene discussed is NPM1; the disease is acute myeloid leukemia.